Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propionyl-L-Carnitine in Mild Ulcerative Colitis
NCT01538251Phase 3Terminated
- Sponsor
- Sigma-Tau
- Start
- Apr 2012
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 3 trial of propionyl-L-carnitine in ulcerative colitis (UC), sponsored by Sigma-Tau. Started Apr 2012; status: terminated.
02
Drugs
propionyl-L-carnitine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01538251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538251.